Patient-controlled analgesic therapy. Part I: Pharmacokinetics of pethidine in the per- and postoperative periods

The influence of anaesthesia and surgery on the pharmacokinetics of pethidine (meperidine) was studied in 12 patients. Plasma pethidine concentrations in central venous blood collected during anaesthesia and the ensuing postoperative hours were by gas chromatography with electron capture detection....

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical pharmacokinetics 1982-03, Vol.7 (2), p.149-163
Hauptverfasser: Tamsen, A, Hartvig, P, Fagerlund, C, Dahlström, B
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 163
container_issue 2
container_start_page 149
container_title Clinical pharmacokinetics
container_volume 7
creator Tamsen, A
Hartvig, P
Fagerlund, C
Dahlström, B
description The influence of anaesthesia and surgery on the pharmacokinetics of pethidine (meperidine) was studied in 12 patients. Plasma pethidine concentrations in central venous blood collected during anaesthesia and the ensuing postoperative hours were by gas chromatography with electron capture detection. Postoperative analgesia was accomplished by patient-controlled intravenous administration of small doses of pethidine. The NONLIN program was used to calculate pharmacokinetic parameters for each individual. A single dose study of pethidine kinetics was carried out in all patients 3 to 5 days postoperatively. Mean +/- SD for peroperative Vd area was 4.3 +/- 1.7L/kg and for the elimination half-life was 6.1 +/- 3.6h. In the postoperative period Vdarea was 3.2 +/- 0.8L/kg and the elimination half-life was 3.2 +/- 1.4h. Plasma clearance increased from a peroperative value of 8.9 +/- 1.9 ml/min/kg to a postoperative value of 12 +/- 3.0 ml/min/kg. The changes in elimination half-life and plasma clearance are significant. The postoperative pharmacokinetics of pethidine were in accordance with those reported for healthy volunteers. The fraction of unbound pethidine was significantly reduced postoperatively - from 0.26 +/- 0.10 (peroperatively) to 0.18 +/- 0.10 (3 to 5 days later).
doi_str_mv 10.2165/00003088-198207020-00004
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_74029236</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>74029236</sourcerecordid><originalsourceid>FETCH-LOGICAL-c170t-ecaae79ff31c804868f5e83b12f36810db4308f47f0cff72dcae92edcd65c9063</originalsourceid><addsrcrecordid>eNo9kMtOAzEMRbMA8f4EpKzYTXGSeWTYIcSjUiW6gPUoTRwamE6GJEXi78lAqTeWj-615UsIZTDjrK6uIZcAKQvWSg4NcCgmVB6QExCMF1Vbi2NyGuN7plkBR-SogboRDE7I51Ilh0MqtB9S8H2PhqpB9W8YnaZpjUGN3zO6VCHR-Q1drlXYKO0_3IDJ6Ui9pSOmtTMZUDdMjgxCkZcYOvqYfJ7yia9f7LyJ5-TQqj7ixa6fkdeH-5e7p2Lx_Di_u10UmjWQCtRKYdNaK5iWUMpa2gqlWDFuRS0ZmFWZn7ZlY0Fb23CjFbYcjTZ1pVuoxRm5-ts7Bv-5xZi6jYsa-14N6Lexa0rgLReTUP4JdfAxBrTdGNxGhe-OQTcl3P0n3O0T_kVltl7ubmxXGzR74y5e8QN763qb</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>74029236</pqid></control><display><type>article</type><title>Patient-controlled analgesic therapy. Part I: Pharmacokinetics of pethidine in the per- and postoperative periods</title><source>MEDLINE</source><source>SpringerNature Journals</source><creator>Tamsen, A ; Hartvig, P ; Fagerlund, C ; Dahlström, B</creator><creatorcontrib>Tamsen, A ; Hartvig, P ; Fagerlund, C ; Dahlström, B</creatorcontrib><description>The influence of anaesthesia and surgery on the pharmacokinetics of pethidine (meperidine) was studied in 12 patients. Plasma pethidine concentrations in central venous blood collected during anaesthesia and the ensuing postoperative hours were by gas chromatography with electron capture detection. Postoperative analgesia was accomplished by patient-controlled intravenous administration of small doses of pethidine. The NONLIN program was used to calculate pharmacokinetic parameters for each individual. A single dose study of pethidine kinetics was carried out in all patients 3 to 5 days postoperatively. Mean +/- SD for peroperative Vd area was 4.3 +/- 1.7L/kg and for the elimination half-life was 6.1 +/- 3.6h. In the postoperative period Vdarea was 3.2 +/- 0.8L/kg and the elimination half-life was 3.2 +/- 1.4h. Plasma clearance increased from a peroperative value of 8.9 +/- 1.9 ml/min/kg to a postoperative value of 12 +/- 3.0 ml/min/kg. The changes in elimination half-life and plasma clearance are significant. The postoperative pharmacokinetics of pethidine were in accordance with those reported for healthy volunteers. The fraction of unbound pethidine was significantly reduced postoperatively - from 0.26 +/- 0.10 (peroperatively) to 0.18 +/- 0.10 (3 to 5 days later).</description><identifier>ISSN: 0312-5963</identifier><identifier>DOI: 10.2165/00003088-198207020-00004</identifier><identifier>PMID: 7067310</identifier><language>eng</language><publisher>Switzerland</publisher><subject>Adult ; Anesthesia, General ; Child ; Chromatography, Gas ; Female ; Half-Life ; Humans ; Intraoperative Period ; Kinetics ; Male ; Meperidine - blood ; Middle Aged ; Postoperative Period ; Preanesthetic Medication ; Protein Binding</subject><ispartof>Clinical pharmacokinetics, 1982-03, Vol.7 (2), p.149-163</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/7067310$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Tamsen, A</creatorcontrib><creatorcontrib>Hartvig, P</creatorcontrib><creatorcontrib>Fagerlund, C</creatorcontrib><creatorcontrib>Dahlström, B</creatorcontrib><title>Patient-controlled analgesic therapy. Part I: Pharmacokinetics of pethidine in the per- and postoperative periods</title><title>Clinical pharmacokinetics</title><addtitle>Clin Pharmacokinet</addtitle><description>The influence of anaesthesia and surgery on the pharmacokinetics of pethidine (meperidine) was studied in 12 patients. Plasma pethidine concentrations in central venous blood collected during anaesthesia and the ensuing postoperative hours were by gas chromatography with electron capture detection. Postoperative analgesia was accomplished by patient-controlled intravenous administration of small doses of pethidine. The NONLIN program was used to calculate pharmacokinetic parameters for each individual. A single dose study of pethidine kinetics was carried out in all patients 3 to 5 days postoperatively. Mean +/- SD for peroperative Vd area was 4.3 +/- 1.7L/kg and for the elimination half-life was 6.1 +/- 3.6h. In the postoperative period Vdarea was 3.2 +/- 0.8L/kg and the elimination half-life was 3.2 +/- 1.4h. Plasma clearance increased from a peroperative value of 8.9 +/- 1.9 ml/min/kg to a postoperative value of 12 +/- 3.0 ml/min/kg. The changes in elimination half-life and plasma clearance are significant. The postoperative pharmacokinetics of pethidine were in accordance with those reported for healthy volunteers. The fraction of unbound pethidine was significantly reduced postoperatively - from 0.26 +/- 0.10 (peroperatively) to 0.18 +/- 0.10 (3 to 5 days later).</description><subject>Adult</subject><subject>Anesthesia, General</subject><subject>Child</subject><subject>Chromatography, Gas</subject><subject>Female</subject><subject>Half-Life</subject><subject>Humans</subject><subject>Intraoperative Period</subject><subject>Kinetics</subject><subject>Male</subject><subject>Meperidine - blood</subject><subject>Middle Aged</subject><subject>Postoperative Period</subject><subject>Preanesthetic Medication</subject><subject>Protein Binding</subject><issn>0312-5963</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1982</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo9kMtOAzEMRbMA8f4EpKzYTXGSeWTYIcSjUiW6gPUoTRwamE6GJEXi78lAqTeWj-615UsIZTDjrK6uIZcAKQvWSg4NcCgmVB6QExCMF1Vbi2NyGuN7plkBR-SogboRDE7I51Ilh0MqtB9S8H2PhqpB9W8YnaZpjUGN3zO6VCHR-Q1drlXYKO0_3IDJ6Ui9pSOmtTMZUDdMjgxCkZcYOvqYfJ7yia9f7LyJ5-TQqj7ixa6fkdeH-5e7p2Lx_Di_u10UmjWQCtRKYdNaK5iWUMpa2gqlWDFuRS0ZmFWZn7ZlY0Fb23CjFbYcjTZ1pVuoxRm5-ts7Bv-5xZi6jYsa-14N6Lexa0rgLReTUP4JdfAxBrTdGNxGhe-OQTcl3P0n3O0T_kVltl7ubmxXGzR74y5e8QN763qb</recordid><startdate>198203</startdate><enddate>198203</enddate><creator>Tamsen, A</creator><creator>Hartvig, P</creator><creator>Fagerlund, C</creator><creator>Dahlström, B</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>198203</creationdate><title>Patient-controlled analgesic therapy. Part I: Pharmacokinetics of pethidine in the per- and postoperative periods</title><author>Tamsen, A ; Hartvig, P ; Fagerlund, C ; Dahlström, B</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c170t-ecaae79ff31c804868f5e83b12f36810db4308f47f0cff72dcae92edcd65c9063</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1982</creationdate><topic>Adult</topic><topic>Anesthesia, General</topic><topic>Child</topic><topic>Chromatography, Gas</topic><topic>Female</topic><topic>Half-Life</topic><topic>Humans</topic><topic>Intraoperative Period</topic><topic>Kinetics</topic><topic>Male</topic><topic>Meperidine - blood</topic><topic>Middle Aged</topic><topic>Postoperative Period</topic><topic>Preanesthetic Medication</topic><topic>Protein Binding</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Tamsen, A</creatorcontrib><creatorcontrib>Hartvig, P</creatorcontrib><creatorcontrib>Fagerlund, C</creatorcontrib><creatorcontrib>Dahlström, B</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Clinical pharmacokinetics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Tamsen, A</au><au>Hartvig, P</au><au>Fagerlund, C</au><au>Dahlström, B</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Patient-controlled analgesic therapy. Part I: Pharmacokinetics of pethidine in the per- and postoperative periods</atitle><jtitle>Clinical pharmacokinetics</jtitle><addtitle>Clin Pharmacokinet</addtitle><date>1982-03</date><risdate>1982</risdate><volume>7</volume><issue>2</issue><spage>149</spage><epage>163</epage><pages>149-163</pages><issn>0312-5963</issn><abstract>The influence of anaesthesia and surgery on the pharmacokinetics of pethidine (meperidine) was studied in 12 patients. Plasma pethidine concentrations in central venous blood collected during anaesthesia and the ensuing postoperative hours were by gas chromatography with electron capture detection. Postoperative analgesia was accomplished by patient-controlled intravenous administration of small doses of pethidine. The NONLIN program was used to calculate pharmacokinetic parameters for each individual. A single dose study of pethidine kinetics was carried out in all patients 3 to 5 days postoperatively. Mean +/- SD for peroperative Vd area was 4.3 +/- 1.7L/kg and for the elimination half-life was 6.1 +/- 3.6h. In the postoperative period Vdarea was 3.2 +/- 0.8L/kg and the elimination half-life was 3.2 +/- 1.4h. Plasma clearance increased from a peroperative value of 8.9 +/- 1.9 ml/min/kg to a postoperative value of 12 +/- 3.0 ml/min/kg. The changes in elimination half-life and plasma clearance are significant. The postoperative pharmacokinetics of pethidine were in accordance with those reported for healthy volunteers. The fraction of unbound pethidine was significantly reduced postoperatively - from 0.26 +/- 0.10 (peroperatively) to 0.18 +/- 0.10 (3 to 5 days later).</abstract><cop>Switzerland</cop><pmid>7067310</pmid><doi>10.2165/00003088-198207020-00004</doi><tpages>15</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0312-5963
ispartof Clinical pharmacokinetics, 1982-03, Vol.7 (2), p.149-163
issn 0312-5963
language eng
recordid cdi_proquest_miscellaneous_74029236
source MEDLINE; SpringerNature Journals
subjects Adult
Anesthesia, General
Child
Chromatography, Gas
Female
Half-Life
Humans
Intraoperative Period
Kinetics
Male
Meperidine - blood
Middle Aged
Postoperative Period
Preanesthetic Medication
Protein Binding
title Patient-controlled analgesic therapy. Part I: Pharmacokinetics of pethidine in the per- and postoperative periods
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-21T13%3A54%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Patient-controlled%20analgesic%20therapy.%20Part%20I:%20Pharmacokinetics%20of%20pethidine%20in%20the%20per-%20and%20postoperative%20periods&rft.jtitle=Clinical%20pharmacokinetics&rft.au=Tamsen,%20A&rft.date=1982-03&rft.volume=7&rft.issue=2&rft.spage=149&rft.epage=163&rft.pages=149-163&rft.issn=0312-5963&rft_id=info:doi/10.2165/00003088-198207020-00004&rft_dat=%3Cproquest_cross%3E74029236%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=74029236&rft_id=info:pmid/7067310&rfr_iscdi=true